Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.

Infectious Diseases

Filter by Year

WDOM Congratulates Dr. Jean Pape on Election to the American Academy of Arts and Sciences

Dr. Jean Pape
GHESKIO founder and the Howard and Carol Holtzmann Professor in Clinical Medicine, Dr. Jean Pape has been elected to the American Academy of Arts and Sciences.

Fund for the Future (FFF) Awards Announced: Advancing Research Careers of Junior Faculty

The Weill Department of Medicine has announced five winners who will receive Fund for the Future (FFF) awards.

WDOM Physician-Scientists Play Key Role in Possibly Curing HIV Infection by Special Stem-Cell Transplant

Drs. Van Besien, Hsu, and Glesby
Drs. Koen Van Besien, Jingmei Hsu, and Marshall Glesby have led a clinical trial involving a patient living with HIV who has now been free of the virus for 14 months.

Women Physicians from the WDOM Highlighted as Portrait of Dr. Elizabeth Blackwell Unveiled at NYP’s Lower Manhattan Hospital

Dr. Blackwell was the first woman in the United States to become an M.D. The occasion was in honor of National Women Physicians Day held on February 3, 2022.

Dr. Morales Receives 2022 Pilot Grant Award of the Mastercard Diversity-Mentorship Collaborative

Dr. Ayana Morales
This one-time grant will support Dr. Morales’s project focused on understanding the role of an oncoprotein, Wilms' Tumor 1, in HIV-Associated Kaposi Sarcoma.

WDOM’s 6th Annual Research Retreat Day Hosts Leader in RNA and Vaccine Research

2021 research retreat
Lectures were provided by WDOM faculty and keynote speaker, Dr. Drew Weissman, who played a major role in critical discoveries that allowed for the mRNA platform to be used in developing vaccines against SARS-CoV.

Dr. Ndhlovu Appointed as Principal Investigator of the HOPE Collaboratory

Dr. Lishomwa Ndhlovu
The HOPE (HIV Obstruction by Programmed Epigenetics) Collaboratory represents a completely new strategy for curing HIV. Utilizing previous knowledge regarding how other viruses have become naturally inactivated over time, the HOPE approach aims to silence and permanently remove HIV from the body.

Dr. Jones Appointed as Principal Investigator of REACH: $28.5 Million NIH-funded Grant

Dr. Brad Jones
As part of The Martin Delaney Collaboratories, which is an NIH flagship funding mechanism, Dr. Jones will be leading REACH (Research Enterprise to Advance a Cure for HIV) in pursuit of a cure for HIV.

Documenting the Impact of HIV on the Host Epigenome During the Earliest Stages of HIV Infection

illustration
The research from Drs. Ndhlovu and Corley finds that abrupt and altered cell-type specific DNA methylation profiles in blood, seen during acute HIV infection, persist despite prompt initiation of antiretroviral therapy.

The Young Investigators Award Recipients of 2021

2021 Young Investigator Award finalists
This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research.